ICC Brazil’s StarYeast® is an alternative to the EU’s vitamin B2 crisis

Published: April 29, 2019

Source : ICC Brazil

An additive prohibited by the EU has been found in large quantities in feed for livestock

European Union authorities are on standby due to the detection of genetically modified organisms (GMOs), found in the feed of livestock in various European countries. The substance in question is a B2 vitamin (riboflavin 80%), used as an additive and made from Bacillus subtillis KCCM-10445, a genetically modified and banned bacteria. Special attention is being given to the propagation of resistant genes, which can lead to antimicrobial resistance in animals and humans.

The European Union has declared itself GMO-free; in other words, it does not allow the use of genetically modified organisms in agriculture and livestock production within EU territories. Vitamin B2 has been banned since September 19^th, 2018, because of the medium- and long-term risks it poses to animals and public health.

Faced with this adversity from the European bloc, the animal nutrition market has adopted strategies to meet animals’ vitamin B2 requirements.

StarYeast®, a product developed by ICC Brazil, is a great alternative solution. It is a dry inactive yeast derived from the fermentation of sugarcane molasses. Aside from its high palatability, StarYeast® offers an excellent nutritional profile and is highly concentrated in B vitamins. Among these is vitamin B2, necessary for animal nutritional requirements. This ICC Brazil product is natural, safe and GMO-free.

Ask about this news release

Source

Related topics

Join to be able to comment.

Once you join Engormix, you will be able to participate in all content and forums.

* Required information

Would you like to discuss another topic? Create a new post to engage with experts in the community.

Create a post

Liliana Longo Borges

ICC

14 de mayo de 2019

Dear David,

Thanks a lot for your consideration about it. We have appreciated so much your participation.

The GMO use in the EU has been limited. According with EFSA, "the frequency of unintended changes may differ between breeding techniques and their occurrence cannot be predicted and needs to be assessed case by case," "similar hazards can be associated with cisgenic and conventionally bred plants, while novel hazards can be associated with intragenic and transgenic plants." In other words, cisgenic approaches, which introduce genes from the same species, should be considered similar in risk to conventional breeding approaches, whilst transgenic plants can come with new hazards. In 2015 Germany, Poland, France, Scotland and several other member states opted out of cultivating GMO crops in their territory.

Reports on the implementation of the GMO legislation can be found here.

Publication of Commission Directive (EU) 2018/350 of 8 March 2018 amending Directive 2001/18/EC, concerning the environmental risk assessment (ERA) of GMOs.
The Commission Directive (EU) 2018/350 of 8 March 2018 amending Directive 2001/18/EC of the European Parliament and of the Council as regards the environmental risk assessment of genetically modified organisms was published on 9 March 2018. This measure brings the requirements on ERA up to date with developments in scientific knowledge and technical progress, while building on the EFSA Guidance Document for the ERA of plants. The measure enters into force on 29 March 2018. EU countries shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 29 September 2019 at the latest.

Publication of Commission Implementing Decision (EU) 2018/1790 of 16 November 2018, repealing Decision 2002/623/EC, establishing guidance notes on the environmental risk assessment of genetically modified organisms.
The Commission Implementing Decision (EU) 2018/1790 of 16 November 2018 repealing Decision 2002/623/EC was published in the Official Journal of the EU, on 20 November 2018.

David Pickard

6 de mayo de 2019

Some clarity is needed here.

The B2 in question is produced by a GMO. In fact, all 'pure' B2 is produced by GMOs. The product in question did not comply with EU regulatory requirements concerning its declared quality with respect to GM content.

The EU has not declared itself GMO free. In fact, regulations exist for the authorisation of GMOs for food and feed use. Of course, the safety bar is set very high and there is little appetite amongst consumers for such products which is probably why there aren't any.